A docetaxel-induced rash on a radiotherapy port.
Quatresooz
Pascale
P
Department of Dermatopathology, University Hospital of Liège, Belgium. pascale.quatresooz@chu.ulg.ac.be
Piérard
Gérald E
GE
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy* / Q000556:secondary; D003131:Combined Modality Therapy / Q000009:adverse effects*; D000077143:Docetaxel; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D011855:Radiodermatitis / Q000175:diagnosis* / Q000209:etiology; D043823:Taxoids / Q000009:adverse effects*; D014067:Tonsillar Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*
D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel